← Leaderboards
Nina A Bickell
Mount Sinai School Of Medicine Of Cuny
$11,712,696
Attributed
$18,983,779
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,124,338 · 10
AHRQ$0 · 3
By mechanism
R01$13,796,279 · 6
P60$9,140,559 · 1
U01$4,171,414 · 1
P30$596,885 · 2
R21$419,201 · 1
P01$0 · 1
Top collaborators
- Derek Leroith7 shared
- Stephanie V. Blank5 shared
- Elena B Elkin5 shared
- Laura J Havrilesky5 shared
- Chung Yin Kong5 shared
- Jason Wright5 shared
- Carol R Horowitz4 shared
- Lynne D. Richardson4 shared
Most similar at Mount Sinai School Of Medicine Of Cuny
Same institution · by research overlap
- Jonathan D. Licht$22,549,031
- Carol R Horowitz$36,702,816
Others in their field
Top investigators on “Incidence”
- Lawrence Corey · Fred Hutchinson Cancer Center$280,538,218
- David M Nathan · Massachusetts Institute Of Technology$138,375,637
- Sharon A Nachman · Johns Hopkins University$135,132,510
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$127,753,192
- James E. Gern · University Of Wisconsin-Madison$123,967,847
- John M Lachin · George Washington University$118,672,444
Research focus
IncidenceMinorityOperative Surgical ProceduresAffectAdjuvantWomanMalignant Breast NeoplasmCessation Of LifeProviderBaseHospitalsRandomized Controlled TrialsCharacteristicsTumorScreeningInterviewMalignant NeoplasmsSiteEffectivenessAfrican AmericanEvaluationEarly DiagnosisProgramsStaging
Grant awards (49)
Standardizing the Quality of Care in Ambulatory Practices$844,997
R01 · FY2025 · MD · contact PI
Comparative Modeling for the Prevention and Control of Uterine Cancer$630,059
U01 · FY2025 · CA
DiSRUPT: Dismantling Structural Racism Underlying the Organization of Ambulatory PracTices: an observational study of clinical desegregation$819,651
R01 · FY2024 · MD · contact PI
Comparative Modeling for the Prevention and Control of Uterine Cancer$803,402
U01 · FY2024 · CA
Community Outreach and Engagement$119,377
P30 · FY2024 · CA · contact PI
Comparative Modeling for the Prevention and Control of Uterine Cancer$856,073
U01 · FY2023 · CA
DiSRUPT: Dismantling Structural Racism Underlying the Organization of Ambulatory PracTices: an observational study of clinical desegregation$845,000
R01 · FY2023 · MD · contact PI
Community Outreach and Engagement$119,377
P30 · FY2023 · CA · contact PI
Comparative Modeling for the Prevention and Control of Uterine Cancer$933,993
U01 · FY2022 · CA
DiSRUPT: Dismantling Structural Racism Underlying the Organization of Ambulatory PracTices: an observational study of clinical desegregation$844,995
R01 · FY2022 · MD · contact PI
Community Outreach and Engagement$119,377
P30 · FY2022 · CA · contact PI
Comparative Modeling for the Prevention and Control of Uterine Cancer$947,887
U01 · FY2021 · CA
Community Outreach and Engagement$119,377
P30 · FY2021 · CA · contact PI
Community Outreach and Engagement$119,377
P30 · FY2020 · CA · contact PI
Insulin Resistance and Breast Cancer Prognosis in Black & White Women$525,063
R01 · FY2017 · CA · contact PI
Insulin Resistance and Breast Cancer Prognosis in Black & White Women$491,333
R01 · FY2016 · CA · contact PI
Insulin Resistance and Breast Cancer Prognosis in Black & White Women$659,497
R01 · FY2015 · CA · contact PI
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities$584,428
R01 · FY2014 · CA · contact PI
Insulin Resistance and Breast Cancer Prognosis in Black & White Women$1
R01 · FY2014 · CA · contact PI
Insulin Resistance and Breast Cancer Prognosis in Black & White Women$678,794
R01 · FY2013 · CA · contact PI
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities$575,982
R01 · FY2013 · CA · contact PI
Racial Disparities, Survival & Secondary Debulking for Ovarian Cancer$323,764
R01 · FY2013 · CA · contact PI
Insulin Resistance and Breast Cancer Prognosis in Black & White Women$40,936
R01 · FY2013 · CA · contact PI
Insulin Resistance and Breast Cancer Prognosis in Black & White Women$721,329
R01 · FY2012 · CA · contact PI
Racial Disparities, Survival & Secondary Debulking for Ovarian Cancer$451,915
R01 · FY2012 · CA · contact PI
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities$318,305
R01 · FY2012 · CA · contact PI
Center for Achieving and Sustaining Improved Health in Harlem$1,543,683
P60 · FY2011 · MD · contact PI
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities$669,621
R01 · FY2011 · CA · contact PI
Racial Disparities, Survival & Secondary Debulking for Ovarian Cancer$528,302
R01 · FY2011 · CA · contact PI
Center for Achieving and Sustaining Improved Health in Harlem$1,544,511
P60 · FY2010 · MD · contact PI
Center for Achieving and Sustaining Improved Health in Harlem$1,400,000
P60 · FY2010 · MD · contact PI
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities$731,834
R01 · FY2010 · CA · contact PI
Implementing Cancer Treatment Measuring & Reporting in Office & Hospital Practice$182,743
R21 · FY2010 · CA · contact PI
Center for Achieving and Sustaining Improved Health in Harlem$1,545,416
P60 · FY2009 · MD · contact PI
Patient Assistance to Reduce Breast Cancer Disparities$397,703
R01 · FY2009 · CA · contact PI
Implementing Cancer Treatment Measuring & Reporting in Office & Hospital Practice$236,458
R21 · FY2009 · CA · contact PI
Center for Achieving and Sustaining Improved Health in Harlem$1,513,088
P60 · FY2008 · MD · contact PI
Patient Assistance to Reduce Breast Cancer Disparities$532,427
R01 · FY2008 · CA · contact PI
Center for Achieving and Sustaining Improved Health in Harlem$1,593,861
P60 · FY2007 · MD · contact PI
Patient Assistance to Reduce Breast Cancer Disparities$272,176
R01 · FY2007 · CA · contact PI
Patient Assistance to Reduce Breast Cancer Disparities$663,825
R01 · FY2006 · CA · contact PI
Patient Assistance to Reduce Breast Cancer Disparities$713,118
R01 · FY2005 · CA
Patient Assistance to Reduce Breast Cancer Disparities$561,283
R01 · FY2004 · CA
ED Staffing and Patient Outcomes$0
R03 · FY2002 · HS
REDUCING UNDERUSE OF EARLY STAGE BREAST CANCER TREATMENT$0
P01 · FY2002 · HS
REDUCING UNDERUSE OF EARLY STAGE BREAST CANCER TREATMENT$0
P01 · FY2001 · HS
ASSESSING THE VARIABILITY IN TIME TO TREATMENT IN SURGER$0
R01 · FY2001 · HS
ASSESSING THE VARIABILITY IN TIME TO TREATMENT IN SURGER$0
R01 · FY2001 · HS
REDUCING UNDERUSE OF EARLY STAGE BREAST CANCER TREATMENT$0
P01 · FY2000 · HS